Cargando…
Core-Shell Polymer-Based Nanoparticles Deliver miR-155-5p to Endothelial Cells
Heart failure occurs in over 30% of the worldwide population and most commonly originates from cardiovascular diseases such as myocardial infarction. microRNAs (miRNAs) target and silence specific mRNAs, thereby regulating gene expression. Because the endogenous miR-155-5p has been ascribed to vascu...
Autores principales: | Antunes, Joana C., Benarroch, Louise, Moraes, Fernanda C., Juenet, Maya, Gross, Marie-Sylvie, Aubart, Mélodie, Boileau, Catherine, Caligiuri, Giuseppina, Nicoletti, Antonino, Ollivier, Véronique, Chaubet, Frédéric, Letourneur, Didier, Chauvierre, Cédric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6610682/ https://www.ncbi.nlm.nih.gov/pubmed/31265949 http://dx.doi.org/10.1016/j.omtn.2019.05.016 |
Ejemplares similares
-
Nanomedicine as a strategy to fight thrombotic diseases
por: Varna, Mariana, et al.
Publicado: (2015) -
Reference Expression Profile of Three FBN1 Transcript Isoforms and Their Association with Clinical Variability in Marfan Syndrome
por: Benarroch, Louise, et al.
Publicado: (2019) -
Marfan Syndrome Variability: Investigation of the Roles of Sarcolipin and Calcium as Potential Transregulator of FBN1 Expression
por: Benarroch, Louise, et al.
Publicado: (2018) -
Fucoidans in Nanomedicine
por: Chollet, Lucas, et al.
Publicado: (2016) -
Quantifying the Genetic Basis of Marfan Syndrome Clinical Variability
por: Grange, Thomas, et al.
Publicado: (2020)